3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
12
Carcinoma, Renal Cell
11
Lymphoma
3
Neoplasms
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Colorectal Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Margins of Excision
1
Kidney Neoplasms
1
Hodgkin Disease
1
Hematologic Neoplasms
1
HTLV-I Infections
1
Carcinoma
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Adenocarcinoma
1
Interventions
Gemcitabine
47
Cisplatin
32
pembrolizumab
28
Paclitaxel
13
Docetaxel
13
avelumab
12
Mitomycin
12
atezolizumab
11
Nivolumab
11
Cystectomy
10
Carboplatin
9
durvalumab
7
Sunitinib
7
apaziquone
6
Doxorubicin
6
BCG Vaccine
6
5-aminolevulinic acid hexyl ester
6
Vinblastine
5
Radiation
5
Platinum
5
Methotrexate
5
Magnetic Resonance Spectroscopy
5
Albumin-Bound Paclitaxel
5
Taxes
4
Standard of Care
4
Sorafenib
4
Radiotherapy
4
Fluorouracil
4
Erlotinib Hydrochloride
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urinary Bladder Neoplasms
×
Interferon alpha-2
×
Clear all
No trials found.